The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Cloning of the Chromosome Breakpoint of Neoplastic B Cells with the t(14;18) Chromosome Translocation
Abstract
From an acute B-cell leukemia cell line, a DNA probe was obtained that was specific for chromosome 18 and flanked the heavy chain joining region of the immunoglobulin heavy chain locus on chromosome 14. This probe detected rearrangement of the homologous DNA segment in the leukemic cells and in follicular lymphoma cells with the t(14:18) chromosome translocation but not in other neoplastic or normal B or T cells. The probe appears to identify bcl-2 , a gene locus on chromosome 18 (band q21) that is unrelated to known oncogenes and may be important in the pathogenesis of B-cell neoplasms with this translocation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dalla-Favera, R., Bregni, M., Erikson, J., Patterson, D., Gallo, R. C., & Croce, C. M. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.24.7824 · Cited by 1,773
Self-citationTaub, R., Kirsch, I., Morton, C., Lenoir, G., Swan, D., Tronick, S., Aaronson, S., & Leder, P. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.24.7837 · Cited by 1,422
Tsujimoto, Y., Yunis, J., Onorato-Showe, L., Erikson, J., Nowell, P. C., & Croce, C. M. (1984) · Science · doi:10.1126/science.6610211 · Cited by 652
Self-citationMarker Band in One Chromosome 14 from Burkitt Lymphomas
MANOLOV, G., & MANOLOVA, Y. (1972) · Nature · doi:10.1038/237033a0 · Cited by 627
Two human c-onc genes are located on the long arm of chromosome 8.
Neel, B. G., Jhanwar, S. C., Chaganti, R. S., & Hayward, W. S. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.24.7842 · Cited by 326
A 14;18 and an 8;14 chromosome translocation in a cell line derived from an acute B-cell leukemia.
Pegoraro, L., Palumbo, A., Erikson, J., Falda, M., Giovanazzo, B., Emanuel, B. S., Rovera, G., Nowell, P. C., & Croce, C. M. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.22.7166 · Cited by 231
Self-citationRecurrent chromosomal defects are found in most patients with non-Hodgkin's-lymphoma
Yunis, J. J., Oken, M. M., Theologides, A., Howe, R. B., & Kaplan, M. E. (1984) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(84)90084-0 · Cited by 183
Self-citationTranscriptional Enhancer Elements in the Mouse Immunoglobulin Heavy Chain Locus
Mercola, M., Wang, X.-F., Olsen, J., & Calame, K. (1983) · Science · doi:10.1126/science.6306772 · Cited by 152
Croce, C. M., Erikson, J., ar-Rushdi, A., Aden, D. P., & Nishikura, K. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.10.3170 · Cited by 84
Self-citation
Cited by
Items 101–170 of 170
Detection of Minimal Residual Cells Carrying the t(14;18) by DNA Sequence Amplification
Lee, M.-S., Chang, K.-S., Cabanillas, F., Freireich, E. J., Trujillo, J. M., & Stass, S. A. (1987) · Science · doi:10.1126/science.3110950 · Cited by 410
Disappearance of the Lymphoid System in Bcl-2 Homozygous Mutant Chimeric Mice
Nakayama, K.-I., Nakayama, K., Negishi, I., Kuida, K., Shinkai, Y., Louie, M. C., Fields, L. E., Lucas, P. J., Stewart, V., Alt, F. W., et al. (1993) · Science · doi:10.1126/science.8372353 · Cited by 397
Nakayama, K., Nakayama, K., Negishi, I., Kuida, K., Sawa, H., & Loh, D. Y. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3700 · Cited by 395
CD95(APO-1/Fas)-Mediated Apoptosis: Live and Let Die
Krammer, P. H. (1998) · Advances in Immunology · doi:10.1016/s0065-2776(08)60402-2 · Cited by 394
Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures
Hallek, M., & Al‐Sawaf, O. (2021) · American Journal of Hematology · doi:10.1002/ajh.26367 · Cited by 393
Cesarman, E., Nador, R. G., Bai, F., Bohenzky, R. A., Russo, J. J., Moore, P. S., Chang, Y., & Knowles, D. M. (1996) · Journal of Virology · doi:10.1128/jvi.70.11.8218-8223.1996 · Cited by 386
Modes of Regulated Cell Death in Cancer
Koren, E., & Fuchs, Y. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0789 · Cited by 371
Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma
Bergsagel, P. L., Chesi, M., Nardini, E., Brents, L. A., Kirby, S. L., & Kuehl, W. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13931 · Cited by 367
Molecular Genetics of Acute Lymphoblastic Leukemia
Armstrong, S. A., & Look, A. T. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.047 · Cited by 362
Cell cycle deregulation in B-cell lymphomas
Sánchez-Beato, M., Sánchez-Aguilera, A., & Piris, M. A. (2003) · Blood · doi:10.1182/blood-2002-07-2009 · Cited by 358
White, E., Sabbatini, P., Debbas, M., Wold, W. S. M., Kusher, D. I., & Gooding, L. R. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.6.2570-2580.1992 · Cited by 349
The manipulation of apoptosis for cancer therapy using BH3-mimetic drugs
Diepstraten, S. T., Anderson, M. A., Czabotar, P. E., Lessene, G., Strasser, A., & Kelly, G. L. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-021-00407-4 · Cited by 346
Bosch, F., Jares, P., Campo, E., Lopez-Guillermo, A., Piris, M., Villamor, N., Tassies, D., Jaffe, E., Montserrat, E., & Rozman, C. (1994) · Blood · doi:10.1182/blood.v84.8.2726.2726 · Cited by 345
Dancescu, M., Rubio-Trujillo, M., Biron, G., Bron, D., Delespesse, G., & Sarfati, M. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.5.1319 · Cited by 344
Activation Of Cellular Oncogenes in Hemopoietic Cells by Chromosome Translocation
(1986) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60200-6 · Cited by 343
Dual or multi-targeting inhibitors: The next generation anticancer agents
Raghavendra, N. M., Pingili, D., Kadasi, S., Mettu, A., & Prasad, S. V. U. M. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.10.021 · Cited by 333
Chen-Levy, Z., Nourse, J., & Cleary, M. L. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.2.701 · Cited by 335
Huang, D. C. S. (1997) · The EMBO Journal · doi:10.1093/emboj/16.15.4628 · Cited by 333
Gribben, J., Freedman, A., Woo, S., Blake, K., Shu, R., Freeman, G., Longtine, J., Pinkus, G., & Nadler, L. (1991) · Blood · doi:10.1182/blood.v78.12.3275.3275 · Cited by 330
Role of mitochondria as the gardens of cell death
Kim, R., Emi, M., & Tanabe, K. (2006) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-005-0111-7 · Cited by 326
Immune Reconstitution and Immunotherapy After Autologous Hematopoietic Stem Cell Transplantation
Guillaume, T., Rubinstein, D. B., & Symann, M. (1998) · Blood · doi:10.1182/blood.v92.5.1471 · Cited by 323
Cell death pathways: intricate connections and disease implications
Kist, M., & Vucic, D. (2021) · The EMBO Journal · doi:10.15252/embj.2020106700 · Cited by 321
Dawson, S.-J., Makretsov, N., Blows, F. M., Driver, K. E., Provenzano, E., Le Quesne, J., Baglietto, L., Severi, G., Giles, G. G., McLean, C. A., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605736 · Cited by 317
Pathogenesis of follicular lymphoma
Kridel, R., Sehn, L. H., & Gascoyne, R. D. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63186 · Cited by 310
Molecular biomarkers in acute myeloid leukemia
Prada-Arismendy, J., Arroyave, J. C., & Röthlisberger, S. (2017) · Blood Reviews · doi:10.1016/j.blre.2016.08.005 · Cited by 304
FACTERA: a practical method for the discovery of genomic rearrangements at breakpoint resolution
Newman, A. M., Bratman, S. V., Stehr, H., Lee, L. J., Liu, C. L., Diehn, M., & Alizadeh, A. A. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu549 · Cited by 303
bcl-2 and Other Genomic Alterations in the Prognosis of Large-Cell Lymphoma
Yunis, J. J., Mayer, M. G., Arnesen, M. A., Aeppli, D. P., Oken, M. M., & Frizzera, G. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904203201605 · Cited by 292
Self-citationCroce, C. M., Isobe, M., Palumbo, A., Puck, J., Ming, J., Tweardy, D., Erikson, J., Davis, M., & Rovera, G. (1985) · Science · doi:10.1126/science.3919442 · Cited by 292
Self-citationApoptosome dysfunction in human cancer
Hajra, K. M., & Liu, J. R. (2004) · Apoptosis · doi:10.1023/b:appt.0000045786.98031.1d · Cited by 291
Targeting Apoptosis Pathways in Cancer Therapy
Fulda, S., & Debatin, K.-M. (2004) · Current Cancer Drug Targets · doi:10.2174/1568009043332763 · Cited by 290
Cause and Consequences of Genetic and Epigenetic Alterations in Human Cancer
Sadikovic, B., Al-Romaih, K., Squire, J., & Zielenska, M. (2008) · Current Genomics · doi:10.2174/138920208785699580 · Cited by 290
Bae, J., Leo, C. P., Hsu, S. Y., & Hsueh, A. J. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909826199 · Cited by 289
Baron, B. W., Nucifora, G., McCabe, N., Espinosa, R., Le Beau, M. M., & McKeithan, T. W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.11.5262 · Cited by 287
BH3-Mimetic Drugs: Blazing the Trail for New Cancer Medicines
Merino, D., Kelly, G. L., Lessene, G., Wei, A. H., Roberts, A. W., & Strasser, A. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.11.004 · Cited by 287
Regulation and Significance of Apoptosis in the Stem Cells of the Gastrointestinal Epithelium
Potten, C. S., Wilson, J. W., & Booth, C. (1997) · STEM CELLS · doi:10.1002/stem.150082 · Cited by 287
Begley, C. G., Aplan, P. D., Davey, M. P., Nakahara, K., Tchorz, K., Kurtzberg, J., Hershfield, M. S., Haynes, B. F., Cohen, D. I., & Waldmann, T. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.6.2031 · Cited by 284
Chronic lymphocytic leukemia: 2017 update on diagnosis, risk stratification, and treatment
Hallek, M. (2017) · American Journal of Hematology · doi:10.1002/ajh.24826 · Cited by 282
ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development
Cang, S., Iragavarapu, C., Savooji, J., Song, Y., & Liu, D. (2015) · Journal of Hematology & Oncology · doi:10.1186/s13045-015-0224-3 · Cited by 281
Transgenic Models of Tumor Development
Adams, J. M., & Cory, S. (1991) · Science · doi:10.1126/science.1957168 · Cited by 280
Apoptosis and non-apoptotic deaths in cancer development and treatment response
de Bruin, E. C., & Medema, J. P. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.07.001 · Cited by 279
Potential of apoptotic pathway-targeted cancer therapeutic research: Where do we stand?
Baig, S., Seevasant, I., Mohamad, J., Mukheem, A., Huri, H. Z., & Kamarul, T. (2016) · Cell Death & Disease · doi:10.1038/cddis.2015.275 · Cited by 279
Significance of immunohistochemistry in breast cancer
Zaha, D. C. (2014) · World Journal of Clinical Oncology · doi:10.5306/wjco.v5.i3.382 · Cited by 277
Phospholipase D Signaling Pathways and Phosphatidic Acid as Therapeutic Targets in Cancer
Bruntz, R. C., Lindsley, C. W., & Brown, H. A. (2014) · Pharmacological Reviews · doi:10.1124/pr.114.009217 · Cited by 276
Chonghaile, T. N., Roderick, J. E., Glenfield, C., Ryan, J., Sallan, S. E., Silverman, L. B., Loh, M. L., Hunger, S. P., Wood, B., DeAngelo, D. J., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0353 · Cited by 275
Role of mitochondrial membrane permeabilization in apoptosis and cancer
Henry-Mowatt, J., Dive, C., Martinou, J.-C., & James, D. (2004) · Oncogene · doi:10.1038/sj.onc.1207534 · Cited by 274
Chromosome translocations: dangerous liaisons revisited
Rowley, J. D. (2001) · Nature Reviews Cancer · doi:10.1038/35106108 · Cited by 274
bcl-2: Role in epithelial differentiation and oncogenesis
Lu, Q.-L., Abel, P., Foster, C. S., & Lalani, E.-N. (1996) · Human Pathology · doi:10.1016/s0046-8177(96)90362-7 · Cited by 265
Prognostic value of chromosomal abnormalities in follicular lymphoma
Tilly, H., Rossi, A., Stamatoullas, A., Lenormand, B., Bigorgne, C., Kunlin, A., Monconduit, M., & Bastard, C. (1994) · Blood · doi:10.1182/blood.v84.4.1043.1043 · Cited by 264
Chronic lymphocytic leukemia: 2015 Update on diagnosis, risk stratification, and treatment
Hallek, M. (2015) · American Journal of Hematology · doi:10.1002/ajh.23979 · Cited by 263
MicroRNAs and chromosomal abnormalities in cancer cells
Calin, G. A., & Croce, C. M. (2006) · Oncogene · doi:10.1038/sj.onc.1209910 · Cited by 263
Self-citationMichaelidis, T. M., Sendtner, M., Cooper, J. D., Airaksinen, M. S., Holtmann, B., Meyer, M., & Thoenen, H. (1996) · Neuron · doi:10.1016/s0896-6273(00)80282-2 · Cited by 262
BCL‐2 expression in adult and embryonic non‐haematopoietic tissues
Lu, Q., Poulsom, R., Wong, L., & Hanby, A. M. (1993) · The Journal of Pathology · doi:10.1002/path.1711690408 · Cited by 261
Targeting the B-Cell Lymphoma/Leukemia 2 Family in Cancer
Davids, M. S., & Letai, A. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.0981 · Cited by 261
Jenkins, M. R., Rudd-Schmidt, J. A., Lopez, J. A., Ramsbottom, K. M., Mannering, S. I., Andrews, D. M., Voskoboinik, I., & Trapani, J. A. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20140964 · Cited by 258
The BCL-2 family of proteins and mitochondrial outer membrane permeabilisation
Birkinshaw, R. W., & Czabotar, P. E. (2017) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2017.04.001 · Cited by 229
Mediation of the antiapoptotic activity of Bcl-xL protein upon interaction with VDAC1 protein
Arbel, N., Ben-Hail, D., & Shoshan-Barmatz, V. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.345918 · Cited by 179
Walensky, L. D., & Gavathiotis, E. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2011.08.009 · Cited by 173
Basu, A. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107943 · Cited by 171
Preudhomme, C., Roumier, C., Hildebrand, M. P., Dallery-Prudhomme, E., Lantoine, D., Laï, J. L., Daudignon, A., Adenis, C., Bauters, F., Fenaux, P., et al. (2000) · Oncogene · doi:10.1038/sj.onc.1203521 · Cited by 135
“Deregulated over-expression of both BCL2 and MYC oncogenes results from their fusion with immunoglobulin (IG) genes (at band 14q32).”
BackgroundKohlhapp, F. J., Haribhai, D., Mathew, R., Duggan, R., Ellis, P. A., Wang, R., Lasater, E. A., Shi, Y., Dave, N., Riehm, J. J., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0759 · Cited by 126
Activation of MYC in a masked t(8;17) translocation results in an aggressive B-cell leukemia.
Gauwerky, C. E., Huebner, K., Isobe, M., Nowell, P. C., & Croce, C. M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.22.8867 · Cited by 125
Self-citationEvolution of Bcl-2 homology motifs: homology versus homoplasy
Aouacheria, A., Rech de Laval, V., Combet, C., & Hardwick, J. M. (2013) · Trends in Cell Biology · doi:10.1016/j.tcb.2012.10.010 · Cited by 103
Crossing paths: interactions between the cell death machinery and growth factor survival signals
Brumatti, G., Salmanidis, M., & Ekert, P. G. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0288-8 · Cited by 85
“Bcl-2, the founding member of the Bcl-2 family of apoptosis regulators, was cloned at the breakpoint of the t(14:18) translocation associated with follicular lymphoma and demonstrated to be the oncogene responsible for this tumour [9, 35].”
BackgroundSmall molecule modulators of protein-protein interactions: selected case studies
Aeluri, M., Chamakuri, S., Dasari, B., Guduru, S. K. R., Jimmidi, R., Jogula, S., & Arya, P. (2014) · Chemical Reviews · doi:10.1021/cr4004049 · Cited by 79
Liu, J., Li, S., Wang, Q., Feng, Y., Xing, H., Yang, X., Guo, Y., Guo, Y., Sun, H., Liu, X., et al. (2024) · Blood · doi:10.1182/blood.2023019706 · Cited by 76
Inflammation and survival pathways: Chronic lymphocytic leukemia as a model system
Chen, L. S., Balakrishnan, K., & Gandhi, V. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.07.039 · Cited by 55
“Bcl-2 was discovered by Tsujimoto in Carlo Croce’s laboratory in Non Hodgkin’s lymphoma cell line with chromosomal t(14;18) [10].”
MethodBH3 Mimetics in Hematologic Malignancies
Klener, P., Sovilj, D., Renesova, N., & Andera, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810157 · Cited by 31
Therapeutics Targeting the Core Apoptotic Machinery
Hamilton, C., Fox, J. P., Longley, D. B., & Higgins, C. A. (2021) · Cancers · doi:10.3390/cancers13112618 · Cited by 26
Small Non-Coding RNAs in Leukemia
Balatti, V., & Croce, C. M. (2022) · Cancers · doi:10.3390/cancers14030509 · Cited by 14
Self-citationSwaroop (2009) · Annual Review of Genomics and Human Genetics · doi:10.1146/genom.2009.10.issue-1 · Cited by 7
Metadata
- Authors
- Tsujimoto, Y., Finger, L. R., Yunis, J., Nowell, P. C., & Croce, C. M.
- Venue
- Science
- Published
- 1984-11-30
- Volume
- 226
- Issue
- 4678
- Pages
- 1097-1099
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2089298737
- Cited by
- 1,769
- References
- 9
- FWCI
- 29.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.